Evaluation of a Novel Hexavalent Humanized Anti-Igf-1r Antibody and Its Bivalent Parental IgG in Diverse Cancer Cell Lines

PLoS ONE - United States
doi 10.1371/journal.pone.0044235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

IGF-1R as an Anti-Cancer Target--Trials and Tribulations

Chinese Journal of Cancer
2013English

Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

Molecular Imaging of IGF-1R in Cancer

Molecular Imaging
Nuclear MedicineRadiologyMolecular MedicineCondensed Matter PhysicsImagingBiotechnologyBiomedical Engineering
2017English

Icaritin, a Novel FASN Inhibitor, Exerts Anti-Melanoma Activities Through IGF-1R/STAT3 Signaling

Oncotarget
Oncology
2016English

A Humanised Anti-Igf-1r Monoclonal Antibody (AVE1642) Enhances Bortezomib-Induced Apoptosis in Myeloma Cells Lacking CD45

British Journal of Cancer
Cancer ResearchOncology
2009English

Combinational Therapy Enhances the Effects of Anti-Igf-1r mAb Figitumumab to Target Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2015English

Safety, Tolerability, and Pharmacokinetics of the Anti-Igf-1r Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Revisiting the IGF-1R as a Breast Cancer Target

npj Precision Oncology
2017English

Anti-Apoptotic Effects of PCP4/PEP19 in Human Breast Cancer Cell Lines: A Novel Oncotarget

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy